Sun Pharma's $9.4 billion Organon acquisition approved
pre-market1 source ↓written by the desknot a recommendation
- acquisition
- $9.4 billion
Sun Pharmaceutical Industries received approval from Organon shareholders for its $9.4 billion acquisition, marking a significant milestone in the deal's progression. This acquisition, focusing on women's health and biosimilars, is poised to be the largest in Sun Pharma's history, pending regulatory approvals. 📈
• Transaction value: $9.4 billion
• Focus areas: Women's health, biosimilars
• Next steps: Awaiting regulatory approvals.
Not investment advice. For informational purposes only.